High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry

Familial Cancer

Volumn 13, Issue 4, 2014, Pages 573-582

  Rosty, Christophe ^a,b,c,d   Walsh, Michael D ^a,e   Lindor, Noralane M ^f   Thibodeau, Stephen N ^g   Mundt, Erin ^h   Gallinger, Steven ^i,j   Aronson, Melyssa ^j   Pollett, Aaron ^j   Baron, John A ^k   Pearson, Sally ^b   Clendenning, Mark ^a,b   Walters, Rhiannon J ^b   Nagler, Belinda N ^b   Crawford, William J ^b   Young, Joanne P ^b   Winship, Ingrid ^a,l   Win, Aung Ko ^m   Hopper, John L ^m,n   Jenkins, Mark A ^m   Buchanan, Daniel D ^a,b,m  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c Envoi Specialist Pathologists   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^f MAYO CLINIC   (United States)

^g MAYO CLINIC   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ CANCER CARE ONTARIO   (Canada)

^j MOUNT SINAI HOSPITAL   (Canada)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l ROYAL MELBOURNE HOSPITAL   (Australia)

^m UNIVERSITY OF MELBOURNE   (Australia)

ⁿ Seoul National University   (South Korea)

more..

Author keywords

Lynch syndrome; Mismatch repair deficiency; Mismatch repair gene mutations; Prostate cancer; Tumor infiltrating lymphocytes

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; DISEASE REGISTRY; GENE MUTATION; GERMLINE MUTATION; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PREVALENCE; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GENE; COLON TUMOR; FEMALE; GENETICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; NUCLEOTIDE SEQUENCE; PROSTATIC NEOPLASMS; REGISTER;

ADULT; AGED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; PREVALENCE; PROSTATIC NEOPLASMS; REGISTRIES;

EID: 84920151520     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-014-9744-1     Document Type: Article

References (32)

1. Win AK, Young JP, Lindor NM et al (2012) Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 30:64–958. doi:10.1200/JCO.2011.39.5590
2. Win AK, Lindor NM, Winship I et al (2013) Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 105:9–274. doi:10.1093/jnci/djs525
3. Win AK, Lindor NM, Young JP et al (2012) Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst 104:72–1363. doi:10.1093/jnci/djs351
4. Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:8–261
5. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42–65. doi:10.1097/GIM.0b013e31818fa2db
6. Jenkins MA, Hayashi S, O’Shea AM et al (2007) Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 133:48–56. doi:10.1053/j.gastro.2007.04.044
7. Walsh MD, Buchanan DD, Cummings MC et al (2010) Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 16:24–2214. doi:10.1158/1078-0432.CCR-09-3058
8. Brieger A, Engels K, Schaefer D et al (2011) Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families. Fam Cancer 10:5–591. doi:10.1007/s10689-011-9455-9
9. Nilbert M, Therkildsen C, Nissen A, Akerman M, Bernstein I (2009) Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum. Fam Cancer 8:13–209. doi:10.1007/s10689-008-9230-8
10. Broaddus RR, Lynch PM, Lu KH, Luthra R, Michelson SJ (2004) Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol 17:11–981
11. Karamurzin Y, Zeng Z, Stadler ZK et al (2012) Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol 43:87–1677. doi:10.1016/j.humpath.2011.12.012
12. Grindedal EM, Moller P, Eeles R et al (2009) Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev 18:7–2460. doi:10.1158/1055-9965.EPI-09-0058
13. Engel C, Loeffler M, Steinke V et al (2012) Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 30:15–4409. doi:10.1200/JCO.2012.43.2278
14. Barrow PJ, Ingham S, O’Hara C et al (2013) The spectrum of urological malignancy in Lynch syndrome. Fam Cancer 12:57–63. doi:10.1007/s10689-012-9573-z
15. Raymond VM, Mukherjee B, Wang F et al (2013) Elevated risk of prostate cancer among men with lynch syndrome. J Clin Oncol 31:8–1713. doi:10.1200/JCO.2012.44.1238
16. Soravia C, van der Klift H, Brundler MA et al (2003) Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum. Am J Med Genet A 121A:62–159. doi:10.1002/ajmg.a.20106
17. Wagner DG, Gatalica Z, Lynch HT, Kohl S, Johansson SL, Lele SM (2010) Neuroendocrine-type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome. Int J Surg Pathol 18:3–550. doi:10.1177/1066896910379406
18. Bauer CM, Ray AM, Halstead-Nussloch BA et al (2011) Hereditary prostate cancer as a feature of Lynch syndrome. Fam Cancer 10:37–42. doi:10.1007/s10689-010-9388-8
19. Newcomb PA, Baron J, Cotterchio M et al (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16:43–2331. doi:10.1158/1055-9965.EPI-07-0648
20. Clendenning M, Walsh MD, Gelpi JB et al (2013) Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Fam Cancer 12:6–563. doi:10.1007/s10689-012-9597-4
21. Young J, Simms LA, Biden KG et al (2001) Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 159:16–2107
22. Walsh MD, Cummings MC, Buchanan DD et al (2008) Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res 14:700–1692. doi:10.1158/1078-0432.CCR-07-1849
23. Lindor NM, Burgart LJ, Leontovich O et al (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20:8–1043
24. Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology, 3rd edn. Lippincott, Philadelphia
25. Ahlbom A, Norell S (1990) Introduction to modern epidemiology, 1st edn. Epidemiology Resources Inc., Stockholm
26. Chen Y, Wang J, Fraig MM et al (2001) Defects of DNA mismatch repair in human prostate cancer. Cancer Res 61:21–4112
27. Cunningham JM, Shan A, Wick MJ et al (1996) Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56:82–4475
28. Egawa S, Uchida T, Suyama K et al (1995) Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 55:29–2418
29. Gao X, Wu N, Grignon D et al (1994) High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 9:2999–3003
30. Dowty JG, Win AK, Buchanan DD et al (2013) Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 34:7–490. doi:10.1002/humu.22262
31. Pande M, Wei C, Chen J et al (2012) Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Fam Cancer 11:7–441. doi:10.1007/s10689-012-9534-6
32. Scott RJ, McPhillips M, Meldrum CJ et al (2001) Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68:27–118